This is a notice of intent, not a request for a proposal. A solicitation document will not be issued and proposals will not be requested. The National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP) intends to solicit, negotiate and award a purchase order on a noncompetitive basis with A.M.P. Instruments LTD, 123 Uziel Street, P.O.B. 16477, Jerusalem 91163, Israel. The National Institute on Drug Abuse requires the following items: 6 ea 8-channel programmable pulse stimulator without computer interface2 ea 8-channel programmable pulse stimulator with USB computer interface4 ea 8-channel programmable pulse stimulator with USB computer interface and touch screen4 ea Isolation unitEstimated Shipping Fees The acquisition is being conducted under simplified acquisition FAR 13 and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. An award to any other source would result in substantial duplication of cost to the Government that is not expected to be recovered through competition. Comments to this announcement, referencing synopsis number NIHDA2010172 may be submitted no later than 4:30 p.m. Eastern Standard Time on July 23, 2010 to NIDA/IRP, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Room 4A326, Baltimore, MD 21224, ATTN: Carol Lindsay

Bid Protests Not Available